Moreover, in the MM bone microenvironment, CD38 decreases during osteoblasts (OBs) differentiation (29) and recently has been demonstrated that CD38 is expressed on the surface of early osteoclasts (OCs) progenitors but it is lost during in-vitro differentiation toward OCs (27). Here, CD38 is linked to Miyoshi myopathy.